Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics
NCT02923336
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Interventions
DRUG:
non selective beta blocker
Sponsor
ALDO TORRE DELGADILLO